ASACOL is indicated in:
- Treatment of the acute phase of mild to moderate ulcerative colitis.
- Maintenance treatment of remission of ulcerative colitis (including patients who cannot tolerate salazosulfapyridine).
- Treatment of the acute phase of Crohn’s disease and maintenance of remission of Crohn’s disease.